Valuing biotechnology companies: Does classification by technology type help?

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.14, Iss.2, 2008-04, pp. : 118-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valuing biotechnology companies using the price earnings ratio

By Loh Jacqueline Brooks Robert

Journal of Commercial Biotechnology, Vol. 12, Iss. 4, 2006-07 ,pp. : 254-260

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

New technologies for neglected diseases: Can tax credits help biotechnology companies advance global health?

By Rao Aarthi

Journal of Commercial Biotechnology, Vol. 17, Iss. 4, 2011-11 ,pp. : 290-292

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Bioethical concerns in Japanese biotechnology companies

By Kato Makina

Journal of Commercial Biotechnology, Vol. 12, Iss. 3, 2006-04 ,pp. : 205-212

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

How biotechnology companies respond to bioethical issues

By Kato M

Journal of Commercial Biotechnology, Vol. 9, Iss. 2, 2003-01 ,pp. : 153-162

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Cloning an industry: Strategy typologies of Shanghai biotechnology companies

By Malone Ken Hales Brent Chan Justin Love Monica Rayner Jeremiah

Journal of Commercial Biotechnology, Vol. 14, Iss. 1, 2008-01 ,pp. : 31-42

Palgrave Macmillan Ltd

Access to resources Recommend Favorite